ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,286Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 336

$1.23M Total Retail Price of All Prescriptions

Rank: 19 out of 336

834 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 834 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

13% of this provider’s 834 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 24,082 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
OMEPRAZOLE 1,149 1,055 1 3
AMLODIPINE BESYLATE 929 861 2 1
FUROSEMIDE 866 782 3 4
POTASSIUM CHLORIDE 744 689 4 9
PRAVASTATIN SODIUM 744 677 4 10
HYDROCODONE-ACETAMINOPHEN 700 516 S3 6 2
METFORMIN HCL 682 603 7 8
LISINOPRIL 662 604 8 6
LEVOTHYROXINE SODIUM 635 592 9 7
SIMVASTATIN 611 579 10 5
CARVEDILOL 510 473 11 13
GABAPENTIN 479 412 12 11
ATORVASTATIN CALCIUM 448 407 13 14
CLONIDINE HCL 418 358 14 32
GLIMEPIRIDE 389 310 15 29
WARFARIN SODIUM 376 303 16 17
ATENOLOL 362 325 17 26
MELOXICAM 296 257 18 19
TRAMADOL HCL 292 259 19 20
MIRTAZAPINE 292 288 19 66
HYDROCHLOROTHIAZIDE 284 273 21 12
CITALOPRAM HBR 258 221 22 21
ZOLPIDEM TARTRATE 255 213 23 18
SPIRONOLACTONE 253 222 24 42
HYDRALAZINE HCL 246 229 25 53
LOSARTAN POTASSIUM 246 228 25 22
KLOR-CON 10 243 211 27 75
CYMBALTA 240 195 28 52
LOSARTAN-HYDROCHLOROTHIAZIDE 237 208 29 45
METOPROLOL SUCCINATE 233 206 30 15
DIOVAN 232 199 31 31
BYSTOLIC 228 223 32 79
METOPROLOL TARTRATE 226 190 33 16
DONEPEZIL HCL 224 224 34 27
ALLOPURINOL 224 202 34 30
ISOSORBIDE MONONITRATE ER 222 191 36 44
AMLODIPINE BESYLATE-BENAZEPRIL 213 184 37 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 209 180 38 23
BISOPROLOL FUMARATE 205 181 39 250
CRESTOR 194 146 40 25
FAMOTIDINE 186 179 41 73
BISOPROLOL-HYDROCHLOROTHIAZIDE 182 182 42 164
SYNTHROID 179 160 43 43
SERTRALINE HCL 162 162 44 33
AMITRIPTYLINE HCL 158 139 R 45 57
DIOVAN HCT 147 140 46 41
DIGOXIN 142 121 47 50
PAROXETINE HCL 140 129 48 64
TAMSULOSIN HCL 138 128 49 38
RANITIDINE HCL 136 133 50 36
ALENDRONATE SODIUM 136 125 50 54
EVISTA 124 124 52 106
NEXIUM 122 119 53 24
EXFORGE 120 108 54 121
CLOPIDOGREL 118 103 55 28
PANTOPRAZOLE SODIUM 116 102 56 40
PREDNISONE 109 100 57 48
NAMENDA 109 109 57 39
LOVASTATIN 109 107 57 34
JANUVIA 108 82 60 67
VENLAFAXINE HCL ER 107 95 61 100
SULFAMETHOXAZOLE-TRIMETHOPRIM 102 93 62 89
DOXAZOSIN MESYLATE 101 101 63 86
SINGULAIR 101 93 63 85
BENAZEPRIL HCL 99 99 65 59
FELODIPINE ER 97 74 66 171
BUSPIRONE HCL 96 76 67 113
VESICARE 94 92 68 190
FENOFIBRATE 94 78 68 72
ESCITALOPRAM OXALATE 92 78 70 69
ZALEPLON 89 76 71 263
LANSOPRAZOLE 87 82 72 167
FLUTICASONE PROPIONATE 87 67 72 49
BUPROPION HCL SR 86 70 74 199
TRAZODONE HCL 84 42 75 46
DILTIAZEM 24HR ER 81 69 76 219
CYCLOBENZAPRINE HCL 80 62 R 77 65
DILTIAZEM 24HR CD 80 78 77 126
LIPITOR 79 66 79 62
DICLOFENAC SODIUM 76 74 80 145
INDAPAMIDE 76 73 80 160
NIFEDICAL XL 75 66 82 205
ZETIA 74 67 83 74
BUPROPION XL 74 74 83 209
METHOTREXATE 72 53 85 187
CELEBREX 72 68 85 105
DOXEPIN HCL 71 31 87 229
KOMBIGLYZE XR 70 66 88 268
PLAVIX 70 55 88 37
TRAMADOL HCL-ACETAMINOPHEN 70 59 88 148
METOCLOPRAMIDE HCL 70 58 88 123
LYRICA 70 57 88 70
GEMFIBROZIL 69 59 93 115
NIFEDIPINE ER 69 67 93 87
WELCHOL 68 68 95 195
FINASTERIDE 67 64 96 156
NIASPAN 65 56 97 139
PREMARIN 65 54 R 97 131
INSULIN SYRINGE 65 58 97 102
MONTELUKAST SODIUM 64 57 100 140
ESTRADIOL 62 62 R 101 129
TORSEMIDE 62 59 101 127
VENLAFAXINE HCL 61 49 103 261
IRBESARTAN 61 58 103 213
ENABLEX 60 60 105 293
ACTOS 58 49 106 119
GLIPIZIDE 58 52 106 71
AZITHROMYCIN 58 50 106 58
ONGLYZA 57 49 109 165
RAMIPRIL 57 53 109 84
TRICOR 56 56 111 108
PROMETHAZINE HCL 56 39 R 111 99
LANTUS 55 39 113 56
TERAZOSIN HCL 54 54 114 166
DOXYCYCLINE HYCLATE 52 50 115 92
DILTIAZEM ER 51 51 116 138
PROPRANOLOL HCL 50 42 117 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.